AdvanSix (ASIX) Stock Forecast & Price Target

AdvanSix is viewed favorably because its integrated chemical platform is showing resilient commercial execution, with 15% year-over-year sales growth and stronger Nylon/Caprolactam and Chemical Intermediates fundamentals driven by reduced global supply and improved pricing mix. The outlook is further supported by a path to breakeven FY26 free cash flow as lower capex, seasonal working-capital benefits, and heavier-than-normal 4Q Plant Nutrients pre-buying offset near-term sulfur cost pressure, while the company targets $30 million of structural cost savings by YE27. Additional upside comes from the $47.4 million USDA grant for Project CENTURY, which lowers the out-of-pocket investment to about $51 million and should add roughly 84,000 tons of annual ammonia capacity, alongside potential 45Q tax credit inflows.

AdvanSix is facing a deteriorating fundamental backdrop as weak demand across most revenue streams, especially the cyclical nylon chain, combines with operating rate cuts and limited near-term catalysts. Record-high sulfur costs have sharply pressured Plant Nutrients margins and drove 3Q26 adjusted EBITDA to $15 million versus $25 million in 3Q25, while revenue rose to $431 million and adjusted EPS fell to a loss of $0.24. Management and analysts also cut 2026E/27E EBITDA to $72 million/$133 million from $97 million/$169 million, signaling that input inflation and soft industrial demand are likely to keep earnings and free cash flow under strain.